Genscript Biotech Corp (1548)

Currency in HKD
33.36
+4.00(+13.62%)
Closed·

1548 Earnings

Latest Release
Sep 11, 2025
EPS / Forecast
-0.02 / 0.62
Revenue / Forecast
518.77M / --
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
06/2025-0.020/0.620518.77M/---103.23%--Free Sign Up
06/2024-0.080/0.230561.37M/---134.78%--Free Sign Up
12/2021-0.960/----/2.07B----Free Sign Up
12/2020-0.370/----/------Free Sign Up
12/20170.010/0.08089.26M/549.69M-87.5%-83.76%Free Sign Up
06/20170.010/--63.39M/577.06M---89.02%Free Sign Up
12/20160.010/--61.54M/483.52M---87.27%Free Sign Up
06/20160.010/--53.20M/------Free Sign Up
12/20150.010/--45.66M/------Free Sign Up

All numbers in

Genscript Biotech Corp Earnings Call Summary for H1/2026

  • GenScript H1 2026 revenue rose 27.3% YoY to HKD 404.2M; adjusted net profit surged 203.3% to HKD 62.5M on strong AIDD demand and operating leverage.
  • Life Science Group revenue grew 28.8% to HKD 319M, beating guidance by 10ppts; adjusted operating profit doubled to HKD 94M on higher-margin validation services.
  • Management raised FY2026 guidance: Life Science Group revenue growth to 25-30% with 25%+ operating margin; ProBio growth also 25-30% with 2027 EBITDA positive.
  • AIDD orders expected to double in H2 2026; company targeting validation services with 20ppt higher margins than traditional protein work, four-day turnaround.
  • Shares fell 4.23% to $24.88 despite strong results; company plans US$130M capex in 2026, funded by US$830M cash without equity financing needed.
Last Updated: 17/08/2026, 01:36
Read Full Transcript

FAQ

What Is Genscript Biotech Corp's Earnings Per Share (TTM)?

The Genscript Biotech Corp EPS (TTM) is -0.29.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.